WST
$375.35
Revenue | $732Mn |
Net Profits | $137Mn |
Net Profit Margins | 18.72% |
West Pharmaceutical Services Inc’s revenue jumped 3.29% since last year same period to $732Mn in the Q4 2023. On a quarterly growth basis, West Pharmaceutical Services Inc has generated -2.06% fall in its revenue since last 3-months.
West Pharmaceutical Services Inc’s net profit jumped 33.01% since last year same period to $137Mn in the Q4 2023. On a quarterly growth basis, West Pharmaceutical Services Inc has generated -15.07% fall in its net profits since last 3-months.
West Pharmaceutical Services Inc’s net profit margin jumped 28.78% since last year same period to 18.72% in the Q4 2023. On a quarterly growth basis, West Pharmaceutical Services Inc has generated -13.28% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.26 |
EPS Estimate Current Year | 1.26 |
West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current quarter stand at 1.26 - a -29.21% fall from last quarter’s estimates.
West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current year stand at 1.26.
Earning Per Share (EPS) | 1.83 |
Dividend Per Share (DPS) | 0.2 |
West Pharmaceutical Services Inc’s earning per share (EPS) jumped 3.39% since last year same period to 1.83 in the Q4 2023. This indicates that the West Pharmaceutical Services Inc has generated 3.39% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
West Pharmaceutical Services Inc declared 0.2 dividend per share during the earnings announcement for Q4 2023.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-02-20 | 1.78 | 1.83 | 2.81% |
2023-10-26 | 1.86 | 2.16 | 16.13% |
2023-04-27 | 1.67 | 1.98 | 18.56% |
2023-07-27 | 1.93 | 2.11 | 9.33% |